For men with high-risk prostate cancer and a five-year life expectancy, treatment rose from 17.3% to 46.5%. The researchers concluded that “overtreatment of men with limited LE [life expectancy ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

that men can have increases of more than two years in their disease trajectory and life expectancy. For advanced prostate cancer in some instances, radiation can be part of a multidisciplinary ...

Overtreatment of older prostate cancer patients with a limited life expectancy has increased over the past two decades among men receiving care in the Veterans Affairs (VA) health system ...